Falsified drugs are less of a problem (anti-malarials) than drug quality, which is a regulatory issue

Summary:

Study authors purchased >10,000 samples of Artemisinin combination treatments in 6 malaria endemic countries and analysed them in a lab. They found that the number of falsified drugs was significantly lower than previously thought (highest was seen in equatorial Guinea at 8%). However, the prevalence of substandard drugs ranged from 6-37%.

Quotes:

“Whilst the numbers of falsified drugs were either none or less than 8  % but the substandard drugs were found between 6.0 and 37  % in all countries where studies were conducted”

Source

Kaur, H., Clarke, S., Lalani, M., Phanouvong, S., Guérin, P., McLoughlin, A., … Schellenberg, D. (2016). Fake anti-malarials: start with the facts. Malaria Journal, 15(1), 86. doi:10.1186/s12936-016-1096-x

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s